Works matching DE "HORMONE receptor positive breast cancer"
Results: 2413
Sick Time.
- Published in:
- 2021
- By:
- Publication type:
- Short Story
Why does hormonal contraception and menopausal hormonal treatment have such a small effect on breast cancer risk?
- Published in:
- Australian & New Zealand Journal of Obstetrics & Gynaecology, 2024, v. 64, n. 5, p. 427, doi. 10.1111/ajo.13825
- By:
- Publication type:
- Article
Initiation of Oral Endocrine Therapy and Survival Benefit Among Women with Early-Stage Breast Cancer.
- Published in:
- Journal of Women's Health (15409996), 2024, v. 33, n. 11, p. 1509, doi. 10.1089/jwh.2023.0971
- By:
- Publication type:
- Article
Impact of Alcohol Consumption on Breast Cancer Incidence and Mortality: The Women's Health Study.
- Published in:
- Journal of Women's Health (15409996), 2024, v. 33, n. 6, p. 705, doi. 10.1089/jwh.2023.1021
- By:
- Publication type:
- Article
Aspirin and Risk of Specific Breast Cancer Subtype in Women with Diabetes.
- Published in:
- Journal of Women's Health (15409996), 2023, v. 32, n. 3, p. 341, doi. 10.1089/jwh.2022.0055
- By:
- Publication type:
- Article
Opportunities to Improve Women's Health: Engaging Racial/Ethnic Diverse Women to Provide Biospecimens for Research.
- Published in:
- Journal of Women's Health (15409996), 2021, v. 30, n. 9, p. 1321, doi. 10.1089/jwh.2020.8502
- By:
- Publication type:
- Article
The Use and Concurrent Use of Side Effect Controlling Medications Among Women on Aromatase Inhibitors.
- Published in:
- Journal of Women's Health (15409996), 2021, v. 30, n. 1, p. 131, doi. 10.1089/jwh.2020.8493
- By:
- Publication type:
- Article
The race to develop oral SERDs and other novel estrogen receptor inhibitors: recent clinical trial results and impact on treatment options.
- Published in:
- Cancer & Metastasis Reviews, 2022, v. 41, n. 4, p. 975, doi. 10.1007/s10555-022-10066-y
- By:
- Publication type:
- Article
Obesity and cancer.
- Published in:
- Cancer & Metastasis Reviews, 2022, v. 41, n. 3, p. 463, doi. 10.1007/s10555-022-10049-z
- By:
- Publication type:
- Article
Quantitative evaluation of the efficacy and safety profiles of two types of targeted inhibitors combined with endocrine therapy in ER+/HER2− metastatic breast cancer.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1387, doi. 10.1007/s00228-024-03715-4
- By:
- Publication type:
- Article
An evidence-based review of the outcome of fulvestrant plus a targeted agent versus fulvestrant alone in treating hormone receptor-positive endocrine therapy-resistant metastatic breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Therapy of isolated locoregional recurrent carcinoma of the breast.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Assessment of ovarian function after chemotherapy in women with early and locally advanced breast cancer from Serbia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Breast cancer presentation and therapy in migrant versus native German patients: contrasting and convergent data of a retrospective monocentric study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase.
- Published in:
- Nature, 2015, v. 522, n. 7554, p. 106, doi. 10.1038/nature14492
- By:
- Publication type:
- Article
Diabetic Ketoacidosis With the Use of Alpelisib in a Patient With Metastatic Breast Cancer Without Diabetes.
- Published in:
- JCEM Case Reports, 2024, v. 2, n. 4, p. 1, doi. 10.1210/jcemcr/luae023
- By:
- Publication type:
- Article
Foreword.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2024, v. 20, n. 1, p. 1
- By:
- Publication type:
- Article
Epidemiological Study of Breast Cancer in Erbil, Kurdistan Region.
- Published in:
- UKH Journal of Science & Engineering, 2023, v. 7, n. 1, p. 11, doi. 10.25079/ukhjse.v7n1y2023.pp11-16
- By:
- Publication type:
- Article
Characteristics and clinical outcome of pT1a-b node-negative breast cancer.
- Published in:
- Northern Clinics of Istanbul, 2021, v. 8, n. 2, p. 124, doi. 10.14744/nci.2020.06332
- By:
- Publication type:
- Article
Prognostic and Predictive Significance of HER2-low Expression in Metastatic Hormone Receptor Positive Breast Cancer Patients Receiving CDK4-6 Inhibitor Therapy.
- Published in:
- European Journal of Therapeutics, 2024, v. 30, n. 5, p. 662, doi. 10.58600/eurjther2151
- By:
- Publication type:
- Article
Adherence to Aromatase Inhibitors among Postmenopausal Breast Cancer Patients in Middle Euphrates Region of Iraq.
- Published in:
- Kerbala Jorunal of Medicine, 2021, v. 14, n. 1, p. 2419
- By:
- Publication type:
- Article
Reduced camptothecin sensitivity of estrogen receptor‐positive human breast cancer cells following exposure to di(2‐ethylhexyl)phthalate (DEHP) is associated with DNA methylation changes.
- Published in:
- Environmental Toxicology, 2019, v. 34, n. 4, p. 401, doi. 10.1002/tox.22694
- By:
- Publication type:
- Article
Early-stage breast cancer: Update on management.
- Published in:
- Medicine Today, 2024, v. 25, n. 4, p. 45
- By:
- Publication type:
- Article
Real-World Observational Study of Incidence and Outcomes in an HR+/HER2– Early Breast Cancer Population with High-Risk of Recurrence in Finland.
- Published in:
- Oncology & Therapy, 2025, v. 13, n. 1, p. 185, doi. 10.1007/s40487-024-00324-0
- By:
- Publication type:
- Article
Real-World Study of Adjuvant Biosimilar Trastuzumab-dkst for HER2-Positive Breast Cancer Treatment in a Brazilian Population.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 437, doi. 10.1007/s40487-024-00284-5
- By:
- Publication type:
- Article
Exploring a Novel Approach to Spare Classic Chemotherapy in HER2-Low, ER-Positive Breast Cancer Based on Trastuzumab Deruxtecan Combined with Endocrine Therapy.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Shared Decision-Making on Using a CDK4/6 Inhibitor plus an Aromatase Inhibitor for HR+/HER2− Metastatic Breast Cancer: A Podcast.
- Published in:
- Oncology & Therapy, 2023, v. 11, n. 4, p. 411, doi. 10.1007/s40487-023-00237-4
- By:
- Publication type:
- Article
Why is it important to define high risk of recurrence in early breast cancer?
- Published in:
- Oncolog-Hematolog, 2023, n. 65, p. 24
- By:
- Publication type:
- Article
Incidental discovery of colonic metastasis in a stage IV breast cancer.
- Published in:
- Oncolog-Hematolog, 2023, n. 64, p. 49
- By:
- Publication type:
- Article
The path followed by a case of HER2-negative HR-positive breast cancer from the moment of diagnosis to the present time: clinical case.
- Published in:
- Oncolog-Hematolog, 2023, n. 64, p. 37
- By:
- Publication type:
- Article
Treatment options for HER2-positive metastatic breast cancer.
- Published in:
- Oncolog-Hematolog, 2020, n. 51, p. 28, doi. 10.26416/onhe.51.2.2020.3191
- By:
- Publication type:
- Article
Abstracts for National Conference of Medical Oncology - 19<sup>th</sup> edition.
- Published in:
- Oncolog-Hematolog, 2019, n. 48, p. 36
- Publication type:
- Article
Palliative Re-Irradiation of Bone Metastases - Case Report.
- Published in:
- Medicina Moderna, 2020, v. 27, n. 4, p. 313, doi. 10.31689/rmm.2020.27.4.313
- By:
- Publication type:
- Article
Luminal B 型乳腺癌不同亚型的临床病理特征及预后生存分析.
- Published in:
- Progress in Modern Biomedicine, 2022, v. 22, n. 12, p. 2366, doi. 10.13241/j.cnki.pmb.2022.12.034
- By:
- Publication type:
- Article
术前CA125、OPN、CXCL8、NLR 联合检测对乳腺癌改良根治术患者术后 复发转移风险的评估价值.
- Published in:
- Progress in Modern Biomedicine, 2022, v. 22, n. 9, p. 1718, doi. 10.13241/j.cnki.pmb.2022.09.024
- By:
- Publication type:
- Article
乳腺癌组织 FOXP3、HMGA2、RASAL2 的表达及与临床病理特征和预后的关系.
- Published in:
- Progress in Modern Biomedicine, 2021, v. 21, n. 20, p. 3959, doi. 10.13241/j.cnki.pmb.2021.20.032
- By:
- Publication type:
- Article
乳腺癌组织表皮生长因子受体、细胞角蛋白5/6、上皮钙黏蛋白表达与预后的关系研究.
- Published in:
- Progress in Modern Biomedicine, 2021, v. 21, n. 16, p. 3079, doi. 10.13241/j.cnki.pmb.2021.16.016
- By:
- Publication type:
- Article
乳腺癌组织表皮生长因子受体、细胞角蛋白 5/6、上皮钙黏蛋白表达与预后的关系研究.
- Published in:
- Progress in Modern Biomedicine, 2021, n. 13, p. 3079, doi. 10.13241/j.cnki.pmb.2021.16.016
- By:
- Publication type:
- Article
3.0 T 磁共振扩散加权成像在乳腺良恶性病变鉴别中的价值及 较优b 值下ADC 值与预后因子相关性研究.
- Published in:
- Progress in Modern Biomedicine, 2020, v. 12, n. 24, p. 4679, doi. 10.13241/j.cnki.pmb.2020.24.017
- By:
- Publication type:
- Article
乳腺癌患者新辅助化疗后ER、PR、HER2、Ki67 表达变化及临床意义.
- Published in:
- Progress in Modern Biomedicine, 2020, v. 20, n. 11, p. 1997, doi. 10.13241/j.cnki.pmb.2020.10.044
- By:
- Publication type:
- Article
乳腺癌患者改良根治术后生活质量调查及复发转移的影响因素分析.
- Published in:
- Progress in Modern Biomedicine, 2020, v. 20, n. 5, p. 984, doi. 10.13241/j.cnki.pmb.2020.05.041
- By:
- Publication type:
- Article
乳腺癌中CELF6的表达水平及其与预后的关系.
- Published in:
- Progress in Modern Biomedicine, 2019, v. 19, n. 19, p. 3601, doi. 10.13241/j.cnki.pmb.2019.19.001
- By:
- Publication type:
- Article
Oxygen-ozone autohemotherapy in breast cancer patients suffering from fatigue and musculoskeletal pain upon aromatase inhibitors treatment: a case-series study.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2023, v. 27, n. 23, p. 11643
- By:
- Publication type:
- Article
Distinct discrepancy in breast cancer organoids recapitulation among molecular subtypes revealed by single‐cell transcriptomes analysis.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 9, p. 1, doi. 10.1002/ctm2.70023
- By:
- Publication type:
- Article
Efficacy and safety of pyrotinib combined with albumin‐bound paclitaxel as first‐line treatment for HER2‐positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single‐arm, phase 2 prospective clinical trial
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 5, p. 1, doi. 10.1002/ctm2.1687
- By:
- Publication type:
- Article
Molecular features of luminal breast cancer defined through spatial and single‐cell transcriptomics.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 1, p. 1, doi. 10.1002/ctm2.1548
- By:
- Publication type:
- Article
Predictive value of DOT1L mutations for clinical outcomes in non‐small‐cell lung cancer patients receiving immune checkpoint inhibitor therapy.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 10, p. 1, doi. 10.1002/ctm2.1430
- By:
- Publication type:
- Article
17‐β‐estradiol reduces surface PD‐L1 expression in estrogen receptor‐positive breast cancer but not type 1 endometrial cancer cells.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 7, p. 1, doi. 10.1002/ctm2.1330
- By:
- Publication type:
- Article
KPNA1 regulates nuclear import of NCOR2 splice variant BQ323636.1 to confer tamoxifen resistance in breast cancer.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 10, p. 1, doi. 10.1002/ctm2.554
- By:
- Publication type:
- Article